Rchr
J-GLOBAL ID:201801012793748694   Update date: Jan. 29, 2025

Yuki Ryuzaburo

Yuki Ryuzaburo
Affiliation and department:
Research field  (3): Pharmaceuticals - health and biochemistry ,  Molecular biology ,  Cell biology
Research keywords  (7): リン酸化シグナル ,  細胞分裂 ,  老化 ,  エピジェネティクス ,  慢性炎症 ,  細胞分化 ,  転写
Research theme for competitive and other funds  (18):
  • 2024 - 2027 がん細胞に特徴的な細胞分裂におけるコレステロール生合成経路の意義解明
  • 2024 - 2027 Reveal the Mechanism of cancer cell division and examination of therapeutic application
  • 2021 - 2024 科学研究費助成事業 若手研究
  • 2018 - 2021 科学研究費助成事業 特別研究員奨励費
  • 2017 - 2019 Mechanism of adipocyte progenitor cells-induced chronic inflammation during aging and obesity
Show all
Papers (35):
  • Ryuji Yasutake, Hiroki Kuwajima, Ryuzaburo Yuki, Junna Tanaka, Youhei Saito, Yuji Nakayama. Phosphorylation of Ephexin4 at Ser-41 contributes to chromosome alignment via RhoG activation in cell division. Journal of Biological Chemistry. 2025
  • Yuki Ikeda, Ryuzaburo Yuki, Youhei Saito, Yuji Nakayama. DeSUMOylating isopeptidase 1 participates in the faithful chromosome segregation and vincristine sensitivity. The FASEB Journal. 2024
  • Mayu Murata, Hiroki Kuwajima, Junna Tanaka, Nanami Hasegawa, Ryuzaburo Yuki, Youhei Saito, Yuji Nakayama. TNK2 Inhibitor (R)-9bMS Causes Polyploidization Through Mitotic Failure by Targeting Aurora B. Cell Biochemistry and Function. 2024
  • Sakura Yanagida, Ryuzaburo Yuki, Youhei Saito, Yuji Nakayama. LAT1 supports mitotic progression through Golgi unlinking in an amino acid transport activity-independent manner. Journal of Biological Chemistry. 2024
  • Junna Tanaka, Hiroki Kuwajima, Ryuzaburo Yuki, Yuji Nakayama. Simvastatin activates the spindle assembly checkpoint and causes abnormal cell division by modifying small GTPases. Cellular signalling. 2024. 119. 111172-111172
more...
MISC (51):
  • 今堀翔太, 今堀翔太, 松本崇宏, 幸龍三郎, 今西孝至, 辻本雅之. ベンラファキシンに起因すると疑われる頭痛に対する薬剤師の介入. 京都薬科大学紀要(Web). 2023. 4. 1
  • 溝口浩晃, 溝口浩晃, 幸龍三郎, 松本崇宏, 今西孝至, 辻本雅之. ダサチニブによる口内炎副作用に対する半夏瀉心湯含嗽の有効性を示した一症例. 京都薬科大学紀要(Web). 2023. 4. 1
  • 澤井健太, 澤井健太, 幸龍三郎, 藤村保夫, 楠本正明, 松村千佳子. 転移性大腸癌に対するラムシルマブ+FOLFIRI療法中に経験したCa拮抗薬による浮腫の一症例. 京都薬科大学紀要(Web). 2022. 3. 1
  • 幸龍三郎, 中山祐治. Role of nuclear tyrosine phosphorylation signaling in cancer progression. 京都薬科大学紀要(Web). 2021. 2. 1
  • 渡辺 寛子, 齊藤 洋平, 三上 大貴, 幸 龍三郎, 中山 祐治. 熱ストレスによる低酸素誘導因子HIF-1α発現の亢進. 日本薬学会年会要旨集. 2020. 140年会. 26F-pm13S
more...
Education (2):
  • 2012 - 2016 Chiba University
  • 2006 - 2012 Chiba University Faculty of Pharmaceutical Sciences
Professional career (1):
  • 薬学博士 (千葉大学)
Work history (3):
  • 2019/10 - 現在 Kyoto Pharmaceutical University
  • 2018/04 - 2019/09 Nippon Medical School
  • 2016/04 - 2019/09 千葉大学医学研究院 長寿医学研究室 特任研究員
Awards (8):
  • 2020/12 - The Pharmaceutical Society of Japan Kansai Branch Award for Young Scientists
  • 2016/03 - Outstanding Excellent Award at Graduate School of Medical and Pharmaceutical Sciences, chiba univeristy
  • 2016/03 - Best Student Presentation Award
  • 2016 - JASSO Repayment Exemption for Outstanding Achievements
  • 2015/03 - Best Presentation Award
Show all
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page